High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, vol.39, no.11, pp.547-558, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 39 Issue: 11
- Publication Date: 2016
- Doi Number: 10.5301/ijao.5000537
- Journal Name: INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.547-558
- Istanbul University Affiliated: Yes
Abstract
Introduction: Serum soluble CD30 (sCD30), a 120-kD glycoprotein that belongs to the tumor necrosis factor receptor family, has been suggested as a marker of rejection in kidney transplant patients. The aim of this study was to evaluate the relationship between sCD30 levels and anti-HLA antibodies, and to compare sCD30 levels in patients undergoing hemodialysis (HD) with and without failed renal allografts and transplant recipients with functioning grafts.